Researchers
Discover all researchers in life sciences
Discover all researchers in life sciences
Researcher at Research Department
Ask questions about Adeola Ajayi's research, publications, and ongoing work
Conducted computational analysis to identify potential inhibitors of the SARS-CoV-2 main protease using compounds from African plants, contributing to the understanding of potential antiviral therapies.
Performed molecular docking studies to evaluate the potential of gallic acid derivatives to inhibit SARS-CoV-2 non-structural proteins, providing insights into potential therapeutic strategies.
Utilized computer-assisted therapeutic discovery approaches to identify novel inhibitors of HSP27, a potential target for anti-cancer therapy.
Investigated the potential of bioactive compounds from African plants to inhibit nitric oxide synthase and arginase, implicated in asthma, using in-silico methods.
Employed in-silico methods, including molecular docking and dynamics simulations, to identify potential Dipeptidyl Peptidase-4 (DPP-4) inhibitors from African medicinal plants for diabetes treatment.
Conducted in-silico molecular docking studies to assess the potential of selected polyphenols to target interleukin-17A in gouty arthritis.
Dr. Adeola Ajayi is a computational biologist specializing in drug discovery, utilizing in-silico methods to identify potential therapeutic agents, particularly for diseases like COVID-19 and cancer. Her research focuses on the application of bioinformatics and molecular docking to understand and target disease mechanisms.
Researchers with overlapping expertise and complementary work
Finding similar researchers...